305 related articles for article (PubMed ID: 31900917)
41. Tumor Cell Autonomous RON Receptor Expression Promotes Prostate Cancer Growth Under Conditions of Androgen Deprivation.
Brown NE; Paluch AM; Nashu MA; Komurov K; Waltz SE
Neoplasia; 2018 Sep; 20(9):917-929. PubMed ID: 30121008
[TBL] [Abstract][Full Text] [Related]
42. Oxidative stress and androgen receptor signaling in the development and progression of castration-resistant prostate cancer.
Shiota M; Yokomizo A; Naito S
Free Radic Biol Med; 2011 Oct; 51(7):1320-8. PubMed ID: 21820046
[TBL] [Abstract][Full Text] [Related]
43. Revisiting the role of Wnt/β-catenin signaling in prostate cancer.
Schneider JA; Logan SK
Mol Cell Endocrinol; 2018 Feb; 462(Pt A):3-8. PubMed ID: 28189566
[TBL] [Abstract][Full Text] [Related]
44. Reduced expression of FILIP1L, a novel WNT pathway inhibitor, is associated with poor survival, progression and chemoresistance in ovarian cancer.
Kwon M; Kim JH; Rybak Y; Luna A; Choi CH; Chung JY; Hewitt SM; Adem A; Tubridy E; Lin J; Libutti SK
Oncotarget; 2016 Nov; 7(47):77052-77070. PubMed ID: 27776341
[TBL] [Abstract][Full Text] [Related]
45. Neuroendocrine differentiation in prostate carcinoma: focusing on its pathophysiologic mechanisms and pathological features.
Alberti C
G Chir; 2010; 31(11-12):568-74. PubMed ID: 21232206
[TBL] [Abstract][Full Text] [Related]
46. Suppression of Akt1-β-catenin pathway in advanced prostate cancer promotes TGFβ1-mediated epithelial to mesenchymal transition and metastasis.
Gao F; Alwhaibi A; Sabbineni H; Verma A; Eldahshan W; Somanath PR
Cancer Lett; 2017 Aug; 402():177-189. PubMed ID: 28602980
[TBL] [Abstract][Full Text] [Related]
47. miR-15a-3p Suppresses Prostate Cancer Cell Proliferation and Invasion by Targeting SLC39A7 Via Downregulating Wnt/β-Catenin Signaling Pathway.
Cui Y; Yang Y; Ren L; Yang J; Wang B; Xing T; Chen H; Chen M
Cancer Biother Radiopharm; 2019 Sep; 34(7):472-479. PubMed ID: 31135177
[No Abstract] [Full Text] [Related]
48. PRKAR2B promotes prostate cancer metastasis by activating Wnt/β-catenin and inducing epithelial-mesenchymal transition.
Sha J; Han Q; Chi C; Zhu Y; Pan J; Dong B; Huang Y; Xia W; Xue W
J Cell Biochem; 2018 Sep; 119(9):7319-7327. PubMed ID: 29761841
[TBL] [Abstract][Full Text] [Related]
49. WDR1 promotes prostate cancer progression through Wnt/β-catenin signaling.
Cheng J; Huo D; Zhang Z; Zhang J; Dong B; Liu Z; Zhou Z; Lu Y
Med Oncol; 2024 May; 41(6):151. PubMed ID: 38743149
[TBL] [Abstract][Full Text] [Related]
50. Frizzled7 Promotes Epithelial-to-mesenchymal Transition and Stemness Via Activating Canonical Wnt/β-catenin Pathway in Gastric Cancer.
Li G; Su Q; Liu H; Wang D; Zhang W; Lu Z; Chen Y; Huang X; Li W; Zhang C; He Y; Fu L; Bi J
Int J Biol Sci; 2018; 14(3):280-293. PubMed ID: 29559846
[TBL] [Abstract][Full Text] [Related]
51. The metastasis suppressor CD82/KAI1 represses the TGF-β
Lee MS; Lee J; Kim YM; Lee H
Prostate; 2019 Sep; 79(12):1400-1411. PubMed ID: 31212375
[TBL] [Abstract][Full Text] [Related]
52. CAPE suppresses migration and invasion of prostate cancer cells via activation of non-canonical Wnt signaling.
Tseng JC; Lin CY; Su LC; Fu HH; Yang SD; Chuu CP
Oncotarget; 2016 Jun; 7(25):38010-38024. PubMed ID: 27191743
[TBL] [Abstract][Full Text] [Related]
53. Interaction of nuclear receptors with the Wnt/beta-catenin/Tcf signaling axis: Wnt you like to know?
Mulholland DJ; Dedhar S; Coetzee GA; Nelson CC
Endocr Rev; 2005 Dec; 26(7):898-915. PubMed ID: 16126938
[TBL] [Abstract][Full Text] [Related]
54. FOXO3a modulates WNT/β-catenin signaling and suppresses epithelial-to-mesenchymal transition in prostate cancer cells.
Liu H; Yin J; Wang H; Jiang G; Deng M; Zhang G; Bu X; Cai S; Du J; He Z
Cell Signal; 2015 Mar; 27(3):510-8. PubMed ID: 25578861
[TBL] [Abstract][Full Text] [Related]
55. Activation of beta-catenin signaling in prostate cancer by peptidyl-prolyl isomerase Pin1-mediated abrogation of the androgen receptor-beta-catenin interaction.
Chen SY; Wulf G; Zhou XZ; Rubin MA; Lu KP; Balk SP
Mol Cell Biol; 2006 Feb; 26(3):929-39. PubMed ID: 16428447
[TBL] [Abstract][Full Text] [Related]
56. Effects of WNT/beta-catenin pathway activation on signaling through T-cell factor and androgen receptor in prostate cancer cell lines.
Cronauer MV; Schulz WA; Ackermann R; Burchardt M
Int J Oncol; 2005 Apr; 26(4):1033-40. PubMed ID: 15753999
[TBL] [Abstract][Full Text] [Related]
57. Chemoradiotherapy Resistance in Colorectal Cancer Cells is Mediated by Wnt/β-catenin Signaling.
Emons G; Spitzner M; Reineke S; Möller J; Auslander N; Kramer F; Hu Y; Beissbarth T; Wolff HA; Rave-Fränk M; Heßmann E; Gaedcke J; Ghadimi BM; Johnsen SA; Ried T; Grade M
Mol Cancer Res; 2017 Nov; 15(11):1481-1490. PubMed ID: 28811361
[TBL] [Abstract][Full Text] [Related]
58. Foxa2 activates the transcription of androgen receptor target genes in castrate resistant prostatic tumors.
Connelly ZM; Yang S; Chen F; Yeh Y; Khater N; Jin R; Matusik R; Yu X
Am J Clin Exp Urol; 2018; 6(5):172-181. PubMed ID: 30510969
[TBL] [Abstract][Full Text] [Related]
59. Exploring the Wnt Pathway as a Therapeutic Target for Prostate Cancer.
Koushyar S; Meniel VS; Phesse TJ; Pearson HB
Biomolecules; 2022 Feb; 12(2):. PubMed ID: 35204808
[TBL] [Abstract][Full Text] [Related]
60. Gone with the Wnt: the canonical Wnt signaling axis is present and androgen dependent in the rodent gubernaculum.
Chen N; Harisis GN; Farmer P; Buraundi S; Sourial M; Southwell BR; Balic A; Hutson JM
J Pediatr Surg; 2011 Dec; 46(12):2363-9. PubMed ID: 22152883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
